For: |
Michiels JJ, Berneman Z, Schroyens W, Lam KH, De Raeve H. PVSG and WHO |
---|---|
URL: | https://www.wjgnet.com/2218-6204/full/v2/i3/71.htm |
Number | Citing Articles |
1 |
Chad C Cherington, Krisstina L Gowin, Ruben A Mesa. Ruxolitinib for treatment of polycythemia vera. Expert Opinion on Orphan Drugs 2015; 3(9): 1085 doi: 10.1517/21678707.2015.1077694
|
2 |
Michiels Jan Jacques, Lam King H, Kate Fibo Ten, Kim Dong-Wook, Kim Myungshin, Shuvaev Vasily, Valster Francisca, Potters Vincent, Schroyens Wilfried, Andreescu Mihaela, Trifa Adrian, Pich Achille, De Raeve Hendrik. Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels. International Journal of Bone Marrow Research 2020; 3(1): 001 doi: 10.29328/journal.ijbmr.1001011
|
3 |
Jan Jacques Michiels, Zwi Berneman, Wilfried Schroyens, Hendrik De Raeve. Changing Concepts of Diagnostic Criteria of Myeloproliferative Disorders and the Molecular Etiology and Classification of Myeloproliferative Neoplasms: From Dameshek 1950 to Vainchenker 2005 and Beyond. Acta Haematologica 2015; 133(1): 36 doi: 10.1159/000358580
|
4 |
Jan Jacques Michiels, Zwi Berneman, Alain Gadisseur, King H. Lam, Hendrik De Raeve, Wilfried Schroyens. Aspirin-Responsive, Migraine-Like Transient Cerebral and Ocular Ischemic Attacks and Erythromelalgia in JAK2<sup>V617F</sup>-Positive Essential Thrombocythemia and Polycythemia Vera. Acta Haematologica 2015; 133(1): 56 doi: 10.1159/000360388
|